相关实验视频

Updated: Jun 12, 2025

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

Published on: November 10, 2008

大脑脊髓液中的接触蛋白显示出痴呆症的不同变化

Besnik Muqaku¹, Sarah Anderl-Straub², Leonie Werner²

¹German Center for Neurodegenerative Diseases (DZNE E.V.), Helmholtzstr. 8/1, 89081, Ulm, Germany.

Journal of neurology

|September 24, 2024

概括

接触因 (CNTN) 蛋白在痴呆症中发生变化. 脑脊髓液中特定的CNTN变化可能有助于诊断阿尔茨海默病和相关痴呆症.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
生物标志物发现发现

背景情况:

接触素 (CNTN) 1-6蛋白与突触功能有关,在神经退行性痴呆症中可能受到失调.
脑脊液 (CSF) 分析提供了 CNTN 网络变化和痴呆症差异诊断的见解.

研究的目的:

开发和验证一种基于质谱的方法,用于同时量化人类中枢神经液中所有六种CNTN蛋白质.
调查各种痴呆症亚型中CSF中CNTN的差异表达模式.

主要方法:

开发了一种多重反应监测 (MRM) 试验,使用稳定的同位素标记标准进行精确的CNTN量化.
从患有阿尔茨海默病 (AD),行为变异前性痴呆症 (bvFTD),帕金森病痴呆症/勒维体痴呆症 (PDD/DLB) 和对照患者的CSF样本进行了分析.
将CNTN水平与已确定的AD核心生物标志物进行了比较.

主要成果:

在bvFTD中观察到CNTN2,CNTN4和CNTN5的下调,在PDD/DLB中观察到CNTN3,CNTN4和CNTN5,相对于AD.
CNTN水平在对照组,bvFTD和PDD/DLB中显示出强烈的相互关联,但在AD中显著较弱的相关性.
在AD中CNTN水平与AD核心生物标志物没有相关性,但它们的联合使用改善了诊断性能.

结论:

在各种类型的痴呆症中,CNTN蛋白质表现出差异性的变化,在AD中选择性地调节了CNTN平衡.
对CNTNs和AD核心生物标志物的综合分析显示,改善痴呆症差异诊断具有前途.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.生物标志物生物标志物大脑脊髓液中的脑脊液.联系我们联系我们痴呆症是一种痴呆症.突触功能障碍突触功能障碍突触功能障碍

更多相关视频

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Published on: December 28, 2017

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.